| For: | Liu YJ, Yan PS, Li J, Jia JF. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol 2005; 11(42): 6601-6606 [PMID: 16425351 DOI: 10.3748/wjg.v11.i42.6601] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i42/6601.htm |
| Number | Citing Articles |
| 1 |
Zheng Zhou, Shaobo Mo, Weixing Dai, Wenqiang Xiang, Lingyu Han, Qingguo Li, Renjie Wang, Lu Liu, Long Zhang, Sanjun Cai, Guoxiang Cai. Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1079-4
|
| 2 |
Dang-xia Zhou, Yun-xia Liu, Ya-hong Xue. Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas. Pathology Research International 2012; 2012 doi: 10.1155/2012/908206
|
| 3 |
SEIYA SAITO, HIROHISA OKABE, MASAYUKI WATANABE, TAKATSUGU ISHIMOTO, MASAAKI IWATSUKI, YOSHIFUMI BABA, YOUHEI TANAKA, JUNJI KURASHIGE, YUJI MIYAMOTO, HIDEO BABA. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncology Reports 2013; 29(4) doi: 10.3892/or.2013.2273
|
| 4 |
Jen-Tsun Lin, Tung-Hao Chang, Cheng-Shong Chang, Wen-Hong Wang, Bi-Wen Su, Kuan-Der Lee, Pey-Jium Chang. Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer. Oral Oncology 2010; 46(5) doi: 10.1016/j.oraloncology.2010.02.011
|
| 5 |
İsmail Biri, Yücel Gültekin, Suzan Bahadır, Kemal Deniz, Kadir Can Küçük. Prognostic significance of metastasis-suppressor gene NM23 in gastric carcinoma. Journal of Surgery and Medicine 2019; doi: 10.28982/josam.582954
|
| 6 |
Inti Zlobec, Ursula Günthert, Luigi Tornillo, Giandomenica Iezzi, Daniel Baumhoer, Luigi Terracciano, Alessandro Lugli. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Histopathology 2009; 55(5) doi: 10.1111/j.1365-2559.2009.03421.x
|
| 7 |
Pu Zhao, Yilin Xu, Yong Wei, Qiong Qiu, Teng-Leong Chew, Yibin Kang, Chonghui Cheng. The CD44s splice isoform is a central mediator for invadopodia activity. Journal of Cell Science 2016; 129(7) doi: 10.1242/jcs.171959
|
| 8 |
Emma L. Woods, Irina V. Grigorieva, Adam C. Midgley, Charlotte V.M. Brown, Yueh-an Lu, Aled O. Phillips, Timothy Bowen, Soma Meran, Robert Steadman. CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β1. Journal of Biological Chemistry 2021; 297(3) doi: 10.1016/j.jbc.2021.100987
|
| 9 |
Caroline A. Heckman, Tanja Holopainen, Kari Alitalo. From Local Invasion to Metastatic Cancer. 2009; doi: 10.1007/978-1-60327-087-8_25
|
| 10 |
Jian-xian Lin, Changhwan Yoon, Ping Li, Qian Yu, Sheng-liang Qiu, Chao-hui Zheng, Sam S. Yoon, Chang-Ming Huang. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy. Journal of Gastrointestinal Surgery 2021; 25(5) doi: 10.1007/s11605-020-04616-4
|
| 11 |
Daniel Brungs, Morteza Aghmesheh, Kara L. Vine, Therese M. Becker, Martin G. Carolan, Marie Ranson. Gastric cancer stem cells: evidence, potential markers, and clinical implications. Journal of Gastroenterology 2016; 51(4) doi: 10.1007/s00535-015-1125-5
|
| 12 |
Xiao-Dong Li, Mei Ji, Jun Wu, Jing-Ting Jiang, Chang-Ping Wu. Clinical Significance of CD44 Variants Expression in Colorectal Cancer. Tumori Journal 2013; 99(1) doi: 10.1177/030089161309900115
|
| 13 |
Yi SUN, Da-lin HE, Qiang MA, Xing-yang WAN, Guo-dong ZHU, Lei LI, Yong LUO, Hui HE, Lin YANG. Comparison of seven screening methods in the diagnosis of bladder cancer. Chinese Medical Journal 2006; 119(21) doi: 10.1097/00029330-200611010-00001
|
| 14 |
Maria Pufulete, Reyad Al‐Ghnaniem Abbadi, Matthew Arno, Mark Ewins, Caroline Green, Estibaliz Aldecoa‐Otalora Astarloa, Tom Sanders, Peter Emery. The influence of folate supplementation on global gene expression in normal colonic mucosa of subjects with colorectal adenoma. Molecular Nutrition & Food Research 2013; 57(4) doi: 10.1002/mnfr.201200617
|
| 15 |
Daniel Brungs, Alistair Lochhead, Anita Iyer, Martin Illemann, Peter Colligan, Nicholas G. Hirst, Ashleigh Splitt, Winston Liauw, Kara L. Vine, Sarennya Pathmanandavel, Martin Carolan, Therese M. Becker, Morteza Aghmesheh, Marie Ranson. Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma. Pathology 2019; 51(5) doi: 10.1016/j.pathol.2019.03.009
|
| 16 |
Thomas Winder, Yan Ning, Dongyun Yang, Wu Zhang, Derek G Power, Pierre Bohanes, Armin Gerger, Peter M. Wilson, Georg Lurje, Laura H Tang, Manish Shah, Heinz‐Josef Lenz. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. International Journal of Cancer 2011; 129(5) doi: 10.1002/ijc.25787
|
| 17 |
Levindo Alves de Oliveira, Ricardo Artigiani-Neto, Daniel Reis Waisberg, Luis Cesar Fernandes, Flávio de Oliveira Lima, Jaques Waisberg. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival. Arquivos de Gastroenterologia 2010; 47(4) doi: 10.1590/S0004-28032010000400008
|
| 18 |
Pantea Rohani, Farahnaz Noroozinia, Parisa Modarresi, Ata Abbasi. CD44 Standard Isoform; Not a Good Marker for Colon Cancer. International Journal of Cancer Management 2017; 10(9) doi: 10.5812/ijcm.9166
|
| 19 |
Julio M. Rios de la Rosa, Annalisa Tirella, Nicola Tirelli. Receptor‐Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid. Advanced Biosystems 2018; 2(6) doi: 10.1002/adbi.201800049
|
| 20 |
Saima Hassan, Cristiano Ferrario, Aline Mamo, Mark Basik. Tissue microarrays: emerging standard for biomarker validation. Current Opinion in Biotechnology 2008; 19(1) doi: 10.1016/j.copbio.2007.10.009
|
| 21 |
Bianca N. Lourenço, Rúben F. Pereira, Cristina C. Barrias, Claudia Fischbach, Carla Oliveira, Pedro L. Granja. Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells. Nanomaterials 2021; 11(2) doi: 10.3390/nano11020295
|
| 22 |
Xiao-Jin Wu, Xiao-Dong Li, Hanze Zhang, Xiaofei Zhang, Zhong-Hua Ning, Yong-Mei Yin, Ye Tian. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer. Journal of International Medical Research 2015; 43(2) doi: 10.1177/0300060514559793
|
| 23 |
Cristiana Branco da Cunha, Carla Oliveira, Xiaogang Wen, Bárbara Gomes, Sónia Sousa, Gianpaolo Suriano, Maritie Grellier, David G Huntsman, Fátima Carneiro, Pedro L Granja, Raquel Seruca. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Laboratory Investigation 2010; 90(11) doi: 10.1038/labinvest.2010.155
|
| 24 |
Yudong Wu, Xia Yu, Mingzhu Liang, Baojun Wang. Correlation analysis of expression and prognosis of TTF‑1 and CD44v6 in undifferentiated lung carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10689
|
| 25 |
Byung Ik Jang, Yuan Li, David Y. Graham, Putao Cen. The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer. Gut and Liver 2011; 5(4) doi: 10.5009/gnl.2011.5.4.397
|
| 26 |
. 2012; doi: 10.70675/6ec2b58bz5ba7z4468z9a3dz9ef13f0a9594
|
| 27 |
Taghreed N Almanaa, Michael E Geusz, Roudabeh J Jamasbi. Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines. BMC Complementary and Alternative Medicine 2012; 12(1) doi: 10.1186/1472-6882-12-195
|
| 28 |
Timothy Craig Allen, Philip T. Cagle. Basic Concepts of Molecular Pathology. Molecular Pathology Library 2009; 2 doi: 10.1007/978-0-387-89626-7_3
|
| 29 |
. 2015; doi: 10.70675/010cda1ez950bz4ba3z803az0531452aa0a8
|
| 30 |
Maria Carmen Fontoura Nogueira da Cruz, Antonio Luiz Amaral Pereira, Fernanda Ferreira Lopes, Cassiano Francisco Weege Nonaka, Raimunda Ribeiro da Silva, Roseana de Almeida Freitas, Lélia Batista de Souza, Leão Pereira Pinto. Immunohistochemical expression of E-cadherin and CD44v6 in squamous cell carcinomas of the lower lip and tongue. Brazilian Dental Journal 2009; 20(1) doi: 10.1590/S0103-64402009000100011
|
| 31 |
Liang Zhou, Ning Zhang, Wenjie Song, Nan You, Qingjun Li, Wei Sun, Yong Zhang, Desheng Wang, Kefeng Dou, Kwan Man. The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma. PLoS ONE 2013; 8(2) doi: 10.1371/journal.pone.0057382
|
| 32 |
Li Lu, Menglin Wu, Longhao Sun, Weidong Li, Weihua Fu, Xuening Zhang, Tong Liu. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer. Medicine 2016; 95(42) doi: 10.1097/MD.0000000000005163
|
| 33 |
Liu Yang, Edi Levi, Shunshi Zhu, Jianhua Du, Adhip P. N. Majumdar. Cancer Stem Cells Biomarkers in Gastric Carcinogenesis. Journal of Gastrointestinal Cancer 2013; 44(4) doi: 10.1007/s12029-013-9534-2
|
| 34 |
Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo Castagnola, Mario Scartozzi, Gavino Faa. CD44: A New Prognostic Marker in Colorectal Cancer?. Cancers 2024; 16(8) doi: 10.3390/cancers16081569
|
| 35 |
Ai-hua Bo, Xue-li Wang, Yong-hua Guo, Hi-feng Li, Xiao-li Zhang, Ping Liang. Expression of CD44s mRNA in gastric carcinoma. Chinese Journal of Cancer Research 2007; 19(2) doi: 10.1007/s11670-007-0146-x
|
| 36 |
Ossama Abbas, Meera Mahalingam. Desmoplasia: not always a bad thing. Histopathology 2011; 58(5) doi: 10.1111/j.1365-2559.2010.03617.x
|
| 37 |
Bianca N. Lourenço, Nora L. Springer, Daniel Ferreira, Carla Oliveira, Pedro L. Granja, Claudia Fischbach. CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling. Integrative Biology 2018; 10(3) doi: 10.1039/C7IB00179G
|
| 38 |
Myoung-Eun Han, Tae-Yong Jeon, Sun-Hwi Hwang, Young-Suk Lee, Hyun-Jung Kim, Hye-Eun Shim, Sik Yoon, Sun-Yong Baek, Bong-Seon Kim, Chi-Dug Kang, Sae-Ock Oh. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cellular and Molecular Life Sciences 2011; 68(21) doi: 10.1007/s00018-011-0672-z
|
| 39 |
Ji-Lin Wang, Wen-Yu Su, Yan-Wei Lin, Hua Xiong, Ying-Xuan Chen, Jie Xu, Jing-Yuan Fang. CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis. Oncotarget 2017; 8(8) doi: 10.18632/oncotarget.14163
|
| 40 |
Ji Zhu, Ye Xu, Weilie Gu, Junjie Peng, Gang Cai, Guoxiang Cai, Wenjie Sun, Weiqi Shen, Sanjun Cai, Zhen Zhang. Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients. Radiation Oncology 2010; 5(1) doi: 10.1186/1748-717X-5-118
|
| 41 |
Timothy Craig Allen, Philip T. Cagle. Molecular Pathology of Lung Diseases. Molecular Pathology Library 2008; 1 doi: 10.1007/978-0-387-72430-0_3
|
| 42 |
Azar Pazhohan, Fardin Amidi, Firoozeh Akbari-Asbagh, Ensiyeh Seyedrezazadeh, Younes Aftabi, Jalal Abdolalizadeh, Mahshad Khodarahmian, Neda Khanlarkhani, Aligholi Sobhani. Expression and shedding of CD44 in the endometrium of women with endometriosis and modulating effects of vitamin D: A randomized exploratory trial. The Journal of Steroid Biochemistry and Molecular Biology 2018; 178 doi: 10.1016/j.jsbmb.2017.12.001
|
| 43 |
Li Lu, Fei Huang, Zhicheng Zhao, Chuan Li, Tong Liu, Weidong Li, Weihua Fu. CD44v6. Medicine 2016; 95(50) doi: 10.1097/MD.0000000000005603
|
| 44 |
Daniele Minardi, Guendalina Lucarini, Alessandra Filosa, Antonio Zizzi, Oriana Simonetti, Anna Maria Offidani, Gianluca d’Anzeo, Roberto Di Primio, Rodolfo Montironi, Giovanni Muzzonigro. Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. Cellular Oncology 2012; 35(5) doi: 10.1007/s13402-012-0098-0
|
| 45 |
Pina Ziranu, Valentina Aimola, Andrea Pretta, Marco Dubois, Raffaele Murru, Nicole Liscia, Flaviana Cau, Mara Persano, Giulia Deias, Enrico Palmas, Francesco Loi, Marco Migliari, Valeria Pusceddu, Marco Puzzoni, Eleonora Lai, Stefano Cascinu, Gavino Faa, Mario Scartozzi. New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression. Cancers 2023; 15(4) doi: 10.3390/cancers15041212
|
| 46 |
Changhwan Yoon, Do Joong Park, Benjamin Schmidt, Nicholas J. Thomas, Hae-June Lee, Teresa S. Kim, Yelena Y. Janjigian, Deirdre J. Cohen, Sam S. Yoon. RETRACTED: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance. Clinical Cancer Research 2014; 20(15) doi: 10.1158/1078-0432.CCR-14-0011
|
| 47 |
Ryoichi Kondo, Kazuo Yoshida, Takashi Eguchi, Nobutaka Kobayashi, Gaku Saito, Kazutoshi Hamanaka, Takayuki Shiina, Makoto Kurai. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases. European Journal of Cardio-Thoracic Surgery 2011; doi: 10.1016/j.ejcts.2011.03.017
|
| 48 |
Ling Tang, Hongming Huang, Yutong Tang, Qing Li, Jue Wang, Dengju Li, Zhaodong Zhong, Ping Zou, Yong You, Yang Cao, Yingjie Kong, Anyuan Guo, Shu Zhou, Huimin Li, Fankai Meng, Yi Xiao, Xiaojian Zhu. CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations. Clinical and Translational Medicine 2022; 12(9) doi: 10.1002/ctm2.1043
|
| 49 |
Min Fang, Yifeng Tao, Zhimin Liu, Hao Huang, Min Lao, Lingsha Huang, Bo Zhu. Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features. BioMed Research International 2017; 2017 doi: 10.1155/2017/8047183
|
| 50 |
Ekaterina Pashkina, Maria Bykova, Maria Berishvili, Yaroslav Lazarev, Vladimir Kozlov. Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy. Cells 2025; 14(2) doi: 10.3390/cells14020061
|
| 51 |
Fonthip Laohavisudhi, Titikorn Chunchai, Natnicha Ketchaikosol, Wacharaporn Thosaporn, Nipon Chattipakorn, Siriporn C. Chattipakorn. Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands. Diagnostics 2022; 12(5) doi: 10.3390/diagnostics12051275
|
| 52 |
Peng Du, Bin Xu, Dachuan Zhang, Yingjie Shao, Xiao Zheng, Xiaodong Li, Yuqi Xiong, Changping Wu, Jingting Jiang. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma. Oncotarget 2017; 8(1) doi: 10.18632/oncotarget.13512
|
| 53 |
Tomoko Umeda, Mitsuaki Ishida, Satoshi Murata, Tsuyoshi Mori, Yuki Kawai, Naoko Itoi, Kaori Tomida, Akie Tanaka, Sachiko Sakai, Mina Kitamura, Yoshihiro Kubota, Ryoji Kushima, Masaji Tani. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component. Breast Cancer 2016; 23(6) doi: 10.1007/s12282-015-0653-4
|
| 54 |
Kamran Ghaffarzadehgan, Mostafa Jafarzadeh, Hamid Reza Raziee, Hamid Reza Sima, Ehsan Esmaili-Shandiz, Hanieh Hosseinnezhad, Ali Taghizadeh-Kermani, Omeed Moaven, Maryam Bahrani. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World Journal of Gastroenterology 2008; 14(41): 6376-6381 doi: 10.3748/wjg.14.6376
|
| 55 |
Kate Dinneen, Anne-Marie Baird, Ciara Ryan, Orla Sheils. The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.600373
|
| 56 |
Jin-Xue Zhou, Liang Zhou, Qing-Jun Li, Wen Feng, Pei-Min Wang, Er-Feng Li, Wen-Jing Gong, Ming-Wen Kou, Wei-Ting Gou, Yan-Ling Yang. Association between high levels of Notch3 expression and high invasion and poor overall survival rates in pancreatic ductal adenocarcinoma. Oncology Reports 2016; 36(5) doi: 10.3892/or.2016.5079
|
| 57 |
Yih-Shou Hsieh, Yao-Ling Lee, Shun-Fa Yang, Jia-Sin Yang, Wei Chen, Shuo-Chueh Chen, Chuen-Ming Shih. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 2007; 58(2) doi: 10.1016/j.lungcan.2007.06.008
|
| 58 |
Yoon Ho Ko, Hye Sung Won, Eun Kyoung Jeon, Sook Hee Hong, Sang Young Roh, Young Seon Hong, Jae Ho Byun, Chan-Kwon Jung, Jin Hyoung Kang. Prognostic significance of CD44s expression in resected non-small cell lung cancer. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-340
|
| 59 |
Saleh Ramezani, Arianna Parkhideh, Pratip K. Bhattacharya, Mary C. Farach-Carson, Daniel A. Harrington. Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.657701
|
| 60 |
Dan Ren, Wen-Ling Wang, Gang Wang, Wei-Wei Chen, Xiao-Kai Li, Guo-Dong Li, Sai-Xi Bai, Hong-Min Dong, Wang-Hua Chen. Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer. Cancer Management and Research 2022; doi: 10.2147/CMAR.S335665
|
| 61 |
Shuang Zhao, Jin-Lan He, Zhi-Xin Qiu, Nian-Yong Chen, Zhuang Luo, Bo-Jiang Chen, Wei-Min Li. Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2014; 15(16) doi: 10.7314/APJCP.2014.15.16.6761
|